HHHadira Hadira

Hadira Hadira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hadira Hadira has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Regenerative agents versus autogenous bone graft for alveolar cleft reconstruction: a systematic review and network meta-analysis

    by Muhammad Irpan Hendrawan, Husni Mubarak, Andi Arfandi Arifuddin, Hadira Hadira, Nurwahida Nurwahida, Muhammad Irfan Rasul, Nining Dwi Suti Ismawati, Irham Taufiqurrahman, Andi Tajrin

    Background: Autogenous iliac crest bone graft is the standard for alveolar cleft reconstruction, but donor-site morbidity has prompted interest in regenerative agents. This review compared and ranked these agents against autogenous bone and one another.Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for network meta-analyses, six databases were searched from January 2000 to June 2026 for controlled studies comparing a regenerative agent with autogenous bone graft. Risk of bias was assessed using version 2 of the Cochrane risk-of-bias tool for randomized trials and the ROBINS-I tool; certainty was assessed using Grading of Recommendations Assessment, Development and Evaluation. A frequentist random-effects network meta-analysis used autogenous bone as the reference and P-scores to rank treatments for new bone formation, bone density, graft volume, and graft success.Results: Twenty-one studies (23 reports) were included. Platelet-rich fibrin (risk ratio [RR], 1.46; 95% confidence interval [CI], 1.07–2.01) and concentrated growth factor (RR, 1.21; 95% CI, 1.02–1.43) were superior to autograft for graft success; platelet-rich fibrin ranked first (P-score, 0.87) and exceeded recombinant human bone morphogenetic protein-2 (RR, 1.44; 95% CI, 1.04–1.99). In one trial, bone marrow aspirate concentrate increased graft volume (standardized mean difference, 2.36; 95% CI, 1.51–3.21). No agent increased new bone formation or bone density. Certainty was moderate for one comparison, low for six, and very low for nine.Conclusion: Autogenous bone remains the volumetric reference standard. The improvement in graft success with platelet-rich fibrin was supported by moderate-certainty evidence and persisted across all sensitivity analyses, including restriction to randomized evidence. The concentrated growth factor finding had low certainty, relied on one retrospective study, and did not persist when analyses were restricted to radiographic outcomes. Adequately powered randomized trials with standardized methods are needed.

  • Open Access

    Effectiveness of Combination Intravenous Ibuprofen and Paracetamol on the Quality of Analgesia after a Third Molar Odontectomy – A Comparative Study

    by Mohammad Gazali, Hadira Hadira, Ahmad Nur Islam, Nilawati Nilawati

    Introduction: Odontectomy is a surgical extraction procedure performed to remove an impacted tooth, which often leads to local inflammation and postoperative complications. Interleukin 6 (IL-6) is closely associated with the pathophysiology of inflammation and pain. Ibuprofen and paracetamol act on different pain stages, strengthening the pain processing barrier. This study aims to assess the effectiveness of a combination of intravenous ibuprofen and paracetamol in comparison to intravenous paracetamol alone on pain intensity and IL-6 levels after a third molar odontectomy.Methods: This comparative clinical study involved 38 patients undergoing odontectomy for third molars, who were divided into two groups of postoperative analgesics. Group A received intravenous ibuprofen (400 mg) and intravenous paracetamol (1,000 mg), while Group B received intravenous paracetamol (1,000 mg). Pain scores were evaluated using Visual Analog Scale (VAS), and IL-6 levels were assessed before the surgery and 24 hours after the procedure.Results: The average pain score was lower in the combination group, even though there was no statistically significant difference in pain levels between the combination group and the paracetamol group (P > 0.05). VAS scores increased two hours following surgery (Group A = 22, Group B = 32) before decreasing eight hours later (Group A = 19, Group B = 22). The IL-6 levels significantly differed between the group receiving intravenous ibuprofen and paracetamol and the group receiving intravenous paracetamol alone (P < 0.05).Conclusion: For controlling inflammation and pain following a third molar odontectomy, the combination of intravenous ibuprofen and paracetamol demonstrated superior analgesic efficacy compared to intravenous paracetamol alone. It represents the most recent choice for managing postoperative pain and inflammation in the oral and maxillofacial region.